Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Alveofact for Moderate to Severe COVID-19
2020-001886-35Phase 2Unknown
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of calfactant in coronavirus disease 2019 (COVID-19), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoints: Change in PaO2/FiO2 ratio after last dose of surfactant, Change in ventilation index after last dose of surfactant and 1 more. Status: unknown.
02
Drugs
calfactant
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001886-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001886-35.